Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 78 contracts
Samples: Loan and Security Agreement (Replimune Group, Inc.), Loan and Security Agreement (enGene Holdings Inc.), Loan and Security Agreement (enGene Holdings Inc.)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower No Loan Party is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 8 contracts
Samples: Loan and Security Agreement (Eloxx Pharmaceuticals, Inc.), Loan and Security Agreement (BiomX Inc.), Loan and Security Agreement (BICYCLE THERAPEUTICS PLC)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. , and Borrower is not aware of any event or circumstance that is likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 8 contracts
Samples: Loan and Security Agreement (Arcus Biosciences, Inc.), Loan and Security Agreement (Gritstone Bio, Inc.), Loan and Security Agreement (Gritstone Bio, Inc.)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. , and Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 6 contracts
Samples: Loan and Security Agreement (Nexx Systems Inc), Loan and Security Agreement (Elixir Pharmaceuticals Inc), Loan and Security Agreement (Panacos Pharmaceuticals, Inc.)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 5 contracts
Samples: Loan and Security Agreement (Mast Therapeutics, Inc.), Loan and Security Agreement (EPIRUS Biopharmaceuticals, Inc.), Loan and Security Agreement (Intelepeer Inc)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. No Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Loan and Security Agreement (Tg Therapeutics, Inc.), Loan and Security Agreement (Proteostasis Therapeutics, Inc.), Loan and Security Agreement (Tg Therapeutics, Inc.)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event or circumstance that is likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 4 contracts
Samples: Loan and Security Agreement (Bluebird Bio, Inc.), Loan and Security Agreement (Sight Sciences, Inc.), Working Capital Facility Agreement (Heron Therapeutics, Inc. /De/)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Such Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Loan and Security Agreement (Cempra Holdings, LLC), Loan and Security Agreement (InfoLogix Inc), Loan and Security Agreement (InfoLogix Inc)
Material Adverse Effect. No Since January 31, 2010, no event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Neither Borrower nor any Guarantor is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 3 contracts
Samples: Loan and Security Agreement (Daegis Inc.), Loan and Security Agreement (Unify Corp), Loan and Security Agreement (Unify Corp)
Material Adverse Effect. No Since June 30, 2016, no event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (Acelrx Pharmaceuticals Inc), Loan and Security Agreement (Acelrx Pharmaceuticals Inc)
Material Adverse Effect. No event or circumstance that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (RedBall Acquisition Corp.), Loan and Security Agreement (RedBall Acquisition Corp.)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower No Loan Party is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (Mesoblast LTD), Loan and Security Agreement (Mesoblast LTD)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Such Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (BIND Therapeutics, Inc), Loan and Security Agreement (Pacira Pharmaceuticals, Inc.)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower No Loan Party or Controlled Entity is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (ATAI Life Sciences N.V.), Loan and Security Agreement (ATAI Life Sciences N.V.)
Material Adverse Effect. No Since December 31, 2011, no event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 2 contracts
Samples: Loan and Security Agreement (Glori Acquisition Corp.), Loan and Security Agreement (Glori Energy Inc.)
Material Adverse Effect. No Since August 9, 2006 , no event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. , and Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is would reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Loan and Security Agreement (Constellation Pharmaceuticals Inc)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. , and Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Loan and Security Agreement (Sirtris Pharmaceuticals, Inc.)
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.. 5.5
Appears in 1 contract
Samples: Loan and Security Agreement (Merrimack Pharmaceuticals Inc)
Material Adverse Effect. No event that has had or could reasonably be expected to have result in a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuingcontinuing since December 31, 2017. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is could reasonably be expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that has occurred that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Loan and Security Agreement (Ocz Technology Group Inc)
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower Issuer is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Material Adverse Effect. No event that has had or could would reasonably be expected to have a Material Adverse Effect has occurred and is continuing. Borrower is not aware of any event likely to occur that is reasonably expected to result in a Material Adverse Effect.
Appears in 1 contract
Samples: Loan and Security Agreement (Immune Pharmaceuticals Inc)
